BORDEAUX, France, May 20, 2024 /PRNewswire/ — TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson’s disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical…